Abstract
The term “enterochromaffin cell” was introduced more than 100 years ago. The cells that are morphologically similar to the enterochromaffin cells have been referred to as “enterochromaffin-like cells”. One of the enterochromaffin-like cell populations in the oxyntic mucosa of stomach is known to produce and store histamine and chromogranin A, and referred to as ECL cells. The biology and the functional morphology and topology of the ECL cells have been extensively studied, since they were discovered 45 years ago. ECLcell histamine plays an important role in the regulation of gastric acid secretion, particularly in response to gastrin stimulation. The timecourse responses of ECL cells to gastrin include mobilization of histamine, hypertrophy, hyperplasia, dysplasia and formation of ECLcell carcinoids. The ECL cells are controlled by a complex regulatory system involving endocrine, paracrine and neural pathways. The physiological significance of ECL cells reflects the nature of their products such as histamine, chromogranin A-derived peptides, Reg protein and yet-unknown hormone.
Keywords: ECL cells, histamine, gastrin, morphology, stomach, enterochromaffin, topology, gastrin stimulation, endocrine, paracrine
Current Medicinal Chemistry
Title: The ECL Cell: Relay Station for Gastric Integrity
Volume: 19 Issue: 1
Author(s): C. -M. Zhao and D. Chen
Affiliation:
Keywords: ECL cells, histamine, gastrin, morphology, stomach, enterochromaffin, topology, gastrin stimulation, endocrine, paracrine
Abstract: The term “enterochromaffin cell” was introduced more than 100 years ago. The cells that are morphologically similar to the enterochromaffin cells have been referred to as “enterochromaffin-like cells”. One of the enterochromaffin-like cell populations in the oxyntic mucosa of stomach is known to produce and store histamine and chromogranin A, and referred to as ECL cells. The biology and the functional morphology and topology of the ECL cells have been extensively studied, since they were discovered 45 years ago. ECLcell histamine plays an important role in the regulation of gastric acid secretion, particularly in response to gastrin stimulation. The timecourse responses of ECL cells to gastrin include mobilization of histamine, hypertrophy, hyperplasia, dysplasia and formation of ECLcell carcinoids. The ECL cells are controlled by a complex regulatory system involving endocrine, paracrine and neural pathways. The physiological significance of ECL cells reflects the nature of their products such as histamine, chromogranin A-derived peptides, Reg protein and yet-unknown hormone.
Export Options
About this article
Cite this article as:
-M. Zhao C. and Chen D., The ECL Cell: Relay Station for Gastric Integrity, Current Medicinal Chemistry 2012; 19 (1) . https://dx.doi.org/10.2174/092986712803414060
DOI https://dx.doi.org/10.2174/092986712803414060 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
DNA Repair Proteins as Molecular Therapeutics for Oxidative and Alkylating Lung Injury
Current Gene Therapy Thioredoxin, Glutathione and Related Molecules in Tumors of the Nervous System
Current Medicinal Chemistry Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
Current Cancer Drug Targets Recent Developments in the Pharmacological Properties of 4'-Geranyloxyferulic Acid, a Colon Cancer Chemopreventive Agent of Natural Origin
Current Drug Targets Posttranscriptional Regulation of p53 and its Targets by RNABinding Proteins
Current Molecular Medicine Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours
Current Signal Transduction Therapy The Role of ING Tumor Suppressors in UV Stress Response and Melanoma Progression
Current Drug Targets Statins and Cancer
Anti-Cancer Agents in Medicinal Chemistry Topical Delivery of Drugs for the Effective Treatment of Fungal Infections of Skin
Current Pharmaceutical Design Design, Synthesis, and Docking Studies of 4H-Chromene and Chromene Based Azo Chromophores: A Novel Series of Potent Antimicrobial and Anticancer Agents
Current Organic Synthesis Expression of α6β4 and α3β1 Integrins in Bullous Pemphigoid and Pemphigus Vulgaris
Letters in Drug Design & Discovery Profile of HBV Integration in the Plasma DNA of Hepatocellular Carcinoma Patients
Current Genomics Novel Strategies for Effective Actinic Keratosis Treatment: A Review
Current Cancer Therapy Reviews Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Epigenetics in Drug Resistance in Cancer
Epigenetic Diagnosis & Therapy (Discontinued) Discovery of New Biomarkers of Cancer Using Proteomics Technology
Current Cancer Therapy Reviews Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery
Endocrine, Metabolic & Immune Disorders - Drug Targets Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Current Pharmaceutical Biotechnology Monoclonal Antibodies Targeting the Epidermal Growth Factor Receptor
Current Drug Targets